Literature DB >> 17715446

Understanding chronic heart failure.

Matthew Fenton1, Michael Burch.   

Abstract

The key principles of chronic heart failure and the development of clinical management strategies are described. The physiological changes in chronic heart failure and the clinical management of children with heart failure are considered, but the treatment of heart failure related to congenital heart disease or the intensive care management of heart failure are not mentioned as both topics require consideration in their own right. A greater understanding of the maladaptive responses to chronic heart failure has enabled targeted therapy to be introduced with consequent improvement in symptoms, reduction in hospitalisation and lower mortality.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17715446      PMCID： PMC2084045          DOI： 10.1136/adc.2005.086397

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  16 in total

1.  Captopril in children with dilated cardiomyopathy: acute and long-term effects in a prospective study of hemodynamic and hormonal effects.

Authors:  H Stern; J Weil; T Genz; W Vogt; K Bühlmeyer
Journal:  Pediatr Cardiol       Date:  1990-01       Impact factor: 1.655

2.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

3.  Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion.

Authors:  R B Wambolt; S L Henning; D R English; G P Bondy; M F Allard
Journal:  J Mol Cell Cardiol       Date:  1997-03       Impact factor: 5.000

4.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

5.  Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

Authors:  M R Bristow; E M Gilbert; W T Abraham; K F Adams; M B Fowler; R E Hershberger; S H Kubo; K A Narahara; H Ingersoll; S Krueger; S Young; N Shusterman
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

6.  Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.

Authors:  B F Uretsky; M Jessup; M A Konstam; G W Dec; C V Leier; J Benotti; S Murali; H C Herrmann; J A Sandberg
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

7.  The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy.

Authors:  A B Lewis; M Chabot
Journal:  Pediatr Cardiol       Date:  1993-01       Impact factor: 1.655

8.  Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Authors:  Milton Packer; Michael B Fowler; Ellen B Roecker; Andrew J S Coats; Hugo A Katus; Henry Krum; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Christoph Staiger; Terry L Holcslaw; Ildiko Amann-Zalan; David L DeMets
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

9.  Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure.

Authors:  A B Covit; G L Schaer; J E Sealey; J H Laragh; R J Cody
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

10.  Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.

Authors:  D M Kaye; G W Lambert; J Lefkovits; M Morris; G Jennings; M D Esler
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094
View more
  2 in total

1.  The Number of GT(n) Repeats in the Hemeoxygenase-1 Gene Promoter is Increased in Pediatric Heart Failure but is Unrelated to Renal, Antioxidant and Anti-inflammatory Markers.

Authors:  Sherif Sayed; Naglaa K Idriss; Andrew Blann; Hayam G Sayyed; D M Raafat; Doaa Fouad; M S K Tawfeek
Journal:  Pediatr Cardiol       Date:  2015-03-31       Impact factor: 1.655

2.  Periodic repolarization dynamics as predictor of risk for sudden cardiac death in chronic heart failure patients.

Authors:  Esther Pueyo; Juan Pablo Martínez; Saúl Palacios; Iwona Cygankiewicz; Antoni Bayés de Luna
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.